Knight Therapeutics | GUD - Dochód Netto





Dochód Netto Zmiana Data
Acasti Pharma USD -938K 2.42M 2025-09
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.01M 153K 2026-03
Aurora Cannabis CAD -71.1M 72.92M 2026-03
Avita Medical AUD -11.62M 1.7M 2025-12
Canopy Growth CAD -157.11M 94.49M 2026-03
Cronos Group USD 32.08M 18.33M 2026-06
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Moderna USD -1.34B 517M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Organigram Holdings CAD -921K 20.89M 2026-03
Organon & Co USD 108M 38M 2026-06
Revvity USD 51.82M 11.1M 2026-06
Tectonic Therapeutic USD -25.24M 6.02M 2026-03
Tilray USD -44.93M 44.61M 2025-09
Viatris USD -118.8M 295.2M 2026-06
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03